Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-01 @ 6:47 AM
Study NCT ID:
NCT00628056
Status:
UNKNOWN
Last Update Posted:
2008-03-04
First Post:
2008-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes
Sponsor:
University Hospital Birmingham
Organization:
Study Overview
Official Title:
Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes
Status:
UNKNOWN
Status Verified Date:
2008-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DDCM
Brief Summary:
Diabetes increases the risk of heart failure. This is mainly due to a disease of the blood vessels supplying the heart muscle and/or high blood pressure, but abnormal metabolism may also contribute. We plan to study the mechanisms involved in this abnormal metabolism, whilst also assessing the effects of a drug called Perhexiline which improves the abnormal metabolism that is present in diabetic patients before the development of heart failure.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| PG/06/104/21466 | None | None | View |